When Drug Cost-Sharing Increases, Patients Newly Diagnosed with a Chronic Illness Delay Starting Medication
Publication Date: January 2009
Publisher(s): RAND Corporation
Author(s): Matthew D. Solomon; Dana P. Goldman; Geoffrey F. Joyce; Jose J. Escarce
Topic:
Type: Brief
Abstract:
Describes a study showing that increasing copayments for prescription drugs causes patients newly diagnosed with hypertension, high cholesterol, and diabetes to delay starting treatment, which in turn increases their risk for heart attack and stroke.
Sign up to receive email newsletters about the
latest research for the topic areas that
interest you.